Deborah H. Telman
Director · AtriCure, Inc.
- 2024
- May 20, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Deborah H. Telman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Daniel Patrick O'Day - $51.19M in GILD purchases and sales in the last 12 months
- Johanna Mercier - $18.17M in GILD purchases and sales in the last 12 months
- Andrew D. Dickinson - $4.38M in GILD purchases and sales in the last 12 months
- Anthony Welters - $2.68M in GILD purchases and sales in the last 12 months
- Jeffrey Bluestone - $1.35M in GILD purchases and sales in the last 12 months
- Sven Wehrwein - $1.32M in ATRC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Deborah H. Telman?
Deborah H. Telman is a corporate insider, tracked as Director of AtriCure, Inc. (ATRC). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Deborah H. Telman last file a Form 4?
The most recent primary Form 4 on record is dated 20 May 2026, one of 7 filings going back to 2024.
Has Deborah H. Telman been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($6.59M) across all tracked filings.
